Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200064980Phase 4Not yet recruiting
Phase 4, open-label trial of lidocaine in obesity (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Plasma concentration and pharmacokinetic parameters of lidocaine. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200064980.